New Guideline Developed for Management of High Blood Pressure
By Elana Gotkine HealthDay Reporter

TUESDAY, Aug. 26, 2025 -- In a new 2025 joint guideline issued by the American Heart Association and the American College of Cardiology, published online Aug. 14 in Circulation, updated recommendations are presented for the management of elevated blood pressure and hypertension.
Daniel W. Jones, M.D., from the University of Mississippi Medical Center in Jackson, and colleagues conducted a comprehensive literature review to update the 2017 guidelines for the management of high blood pressure in adults.
The authors note that the overarching blood pressure treatment goal is <130/80 mm Hg for all adults. Screening should be implemented for all adults in the community, and guideline-based recommendations should be implemented to improve blood pressure control. Lifestyle changes are strongly recommended for all adults to prevent or treat elevated blood pressure and hypertension, including maintaining or achieving a healthy weight, following a heart-healthy eating pattern, reducing sodium intake, increasing dietary potassium intake, adopting a moderate physical activity program, managing stress, and reducing or eliminating alcohol.
For all adults with an average blood pressure ≥140/90 mm Hg and/or for selected adults with average blood pressure ≥130/80 mm Hg, including those at risk according to the American Heart Association PREVENT risk calculator, initiation of medication therapy is recommended in addition to lifestyle interventions.
The authors of the guideline also recommend use of the ratio of urine albumin to creatinine for all patients with high blood pressure and expand indications for use of the plasma aldosterone-to-renin ratio test as a screening tool for primary aldosteronism in more patients.
"It is important for people to be aware of the recommended blood pressure goals and understand how healthy lifestyle behaviors and appropriate medication use can help them achieve and maintain optimal blood pressure," Jones said in a statement.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-08-27 06:00
Read more

- Adjusted Mortality Rate Increased for Seniors After Hurricane-Related Flooding
- Nike Co-Founder And Wife Donate $2B to Cancer Research at OHSU, Largest U.S. University Gift
- Volunteering Slows Brain Aging
- Stalking Victims At Higher Risk For Future Heart Problems
- Weather Disasters Impacted Counties With More Than 60 Percent of Drug Production Facilities
- FDA Approves Ajovy for Migraine Prevention in Children and Teens
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions